RE: RE: Endo-Urocidin new study on refractory patiSorry Art. I just discovered this board four days ago. And I just heard about ENDO planning to scrap the whole PIIIb study planned by Bioniche and focus on the refractory patients. All along, the PIIIb was to study the Urocidin vs BCG as first line and safety issues, which is completely different than the PIIIa so makes a lot of sense.
Please excuse my ignorance if there had beed discussions before. Can you point me to a few links on that?